Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,755,440
+$338,928 QoQ
Shares Held
6,976
+7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,069
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BALDWIN WEALTH PARTNERS LLC/MA holds $27,785,455 across 7 Drug Manufacturers - General names. ABBV ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,436 | $16,364,810 | |
| 2 | NVS |
Novartis AG
|
27,679 | $4,337,852 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,669 | $2,013,466 | |
| 4 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
6,976 | $1,755,440 | |
| 6 | AMGN |
Amgen Inc
|
2,413 | $873,795 | |
| 7 | PFE |
Pfizer Inc
|
23,579 | $567,782 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,755,440 | 6,976 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,416,512 | 6,513 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,747,720 | 7,649 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,832,639 | 7,915 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,443,566 | 7,777 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,625,456 | 7,758 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,413,070 | 7,952 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,966,900 | 9,960 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,079,546 | 6,294 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,151,600 | 6,324 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,048,991 | 6,769 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $1,130,769 | 7,586 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,947,387 | 14,454 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,303,533 | 14,454 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,335,910 | 14,454 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,583,678 | 11,800 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,968,871 | 12,855 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,083,924 | 12,855 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $684,447 | 5,055 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $529,102 | 4,905 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $552,499 | 4,905 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $530,819 | 4,905 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $525,570 | 4,905 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $499,788 | 5,706 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $563,651 | 5,741 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $437,406 | 5,741 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||